Haleon’s listing shows the problems afflicting the London Stock Exchange
A big debut for a firm that sells toothpaste
The london stock exchange welcomed its largest new entrant in over a decade on July 18th. GlaxoSmithKline (gsk), a pharmaceuticals giant included in the ftse 100 index of leading shares, spun out its consumer health-care division in order to focus on new drugs and vaccines. Each of gsk’s shareholders received one share in Haleon, the new firm, for every gsk share they owned. Haleon started trading at a market capitalisation of £30.5bn ($36.4bn).
This article appeared in the Britain section of the print edition under the headline “Don’t gloat about the float”
Britain July 23rd 2022
- The life-sciences industry is a jewel in Britain’s economy
- Haleon’s listing shows the problems afflicting the London Stock Exchange
- Rishi Sunak and Liz Truss will battle to be Britain’s next prime minister
- The Tories seem to be cooling on Boris Johnson’s signature policy
- A superhighway for drones to fly between British cities
- The choice between Rishi Sunak and Liz Truss
From the July 23rd 2022 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Britain
Has the Royal Navy become too timid?
A new paper examines how its culture has changed
A plan to reorganise local government in England runs into opposition
Turkeys vote against Christmas
David Lammy’s plan to shake up Britain’s Foreign Office
Diplomats will be tasked with growing the economy and cutting migration
Britain’s government has spooked markets and riled businesses
Tax rises were inevitable. Such a shaky start was not
Labour’s credibility trap
Who can believe Rachel Reeves?